Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
Select Region
Selecting your primary region ensures you get the stories that matter to you first.
TORONTO – Canadian securities regulators are cautioning investors looking for a quick high to be cautious when investing in medical marijuana stocks.
The Canadian Securities Administrators says a significant number of companies have announced plans to begin growing and selling medical marijuana.
And in many cases the securities regulator says, just the announcement of those plans have driven share prices higher.
The CSA says investors need to be aware that companies cannot legally grow and sell medical marijuana without a licence from Health Canada and that takes significant time and cost to obtain.
New regulations regarding medical marijuana were enacted by the federal government April 1. The move opened production up to the commercial sector.
As of late last month, the department had received more than 850 applications from companies wanting to be medical marijuana suppliers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.